Insider · CIK 0001916664
David Owens
Files at NXL (Nexalin Technology, Inc.). First filing Oct 30, 2024, latest Oct 30, 2024.
In brief
David Owens files SEC Form 4 as officer and director at NXL (Nexalin Technology, Inc.). Since Oct 30, 2024, David Owens has reported 1 open-market buy worth $1,095 and 0 open-market sells worth $0, the latest filed on Oct 30, 2024.
A track record needs three past buys with six months of prices behind them; David Owens has 0, so none is measured yet.
The newest scored trade: bought $1,095 of NXL on Oct 28, 2024, filed Oct 30, 2024, scored 10 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NXL: Nexalin Technology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)*derivative | +1,000,000 | $0.00 | $0 | 2,484,809 | Dec 23, 2025 |
| Sep 29, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Common stock | +36,459 | $0.00 | $0 | 191,252 | Sep 30, 2025 |
| Sep 12, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +203,125 | $0.00 | $0 | 1,384,809 | Sep 12, 2025 |
| Sep 12, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 1,484,809 | Sep 12, 2025 |
| Oct 28, 2024 | NXL Nexalin Technology, Inc. | POpen-market purchase Common stock | +500 | $2.19 | $1,095 | 148,293 | Oct 30, 2024 |
Questions about David Owens
Answered from the filings on this page, as of the latest one.
Is David Owens buying or selling?
Not in the last 12 months. David Owens's latest open-market trade on SEC Form 4 was bought $1,095 of NXL on Oct 28, 2024.
How did David Owens's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Owens has 0.
Where does David Owens file Form 4?
David Owens has filed Form 4 at NXL (Nexalin Technology, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.